In last trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 3.24 million shares changing hands with its beta currently measuring 1.98. Company’s recent per share price level of $0.31 trading at -$0.04 or -11.11% at ring of the bell on the day assigns it a market valuation of $3.13M. That closing price of PTPI’s stock is at a discount of -632.26% from its 52-week high price of $2.27 and is indicating a premium of 29.03% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.25 million shares which gives us an average trading volume of 1.48 million if we extend that period to 3-months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Upright in the red during last session for losing -11.11%, in the last five days PTPI remained trading in the red while hitting it’s week-highest on Tuesday, 12/17/24 when the stock touched $0.31 price level, adding 47.06% to its value on the day. Petros Pharmaceuticals Inc’s shares saw a change of -77.87% in year-to-date performance and have moved -10.88% in past 5-day. Petros Pharmaceuticals Inc (NASDAQ:PTPI) showed a performance of 24.29% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 0.72 days to cover the short interests.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Insiders are in possession of 8.10% of company’s total shares while institution are holding 2.29 percent of that, with stock having share float percentage of 2.49%. Investors also watch the number of corporate investors in a company very closely, which is 2.29% institutions for Petros Pharmaceuticals Inc that are currently holding shares of the company.